Dapsone-induced motor polyneuropathy in a patient with leprosy.
Pavithran
K
K
Satish
T C
TC
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015439:Leprosy, Borderline / Q000188:drug therapy*; D008297:Male; D016472:Motor Neuron Disease / Q000139:chemically induced* / Q000175:diagnosis*; D011239:Prednisolone / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D007917:Leprostatic Agents; D003622:Dapsone; D011239:Prednisolone; D002991:Clofazimine; D012293:Rifampin